Transmission control and drug resistance in malaria: A crucial interaction

Parasitology Today

Volumn 15, Issue 6, 1999, Pages 238-240

  Molyneux, D H ^a   Floyd, K ^a   Barnish, G ^a   Fevre E M ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; CHLOROQUINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; PYRIMETHAMINE; QUININE;

ARTICLE; CHEMOTHERAPY; CHILDHOOD MORTALITY; DISEASE TRANSMISSION; DRUG COST; DRUG DEVELOPMENT; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALARIA; MALARIA CONTROL; MORBIDITY; ORAL DRUG ADMINISTRATION; PARASITE DEVELOPMENT; VECTOR CONTROL;

EID: 0033151517     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(99)01453-2     Document Type: Review

References (19)

1. World Health Organization (1993) A Global Strategy for Malaria Control, WHO
2. Trape, J-F. and Rogier, C. (1996) Combating malaria morbidity and mortality by reducing transmission. Parasitol. Today 12, 236-240
3. Lengeler, C., Smith, T.A. and Schellenberg, J.A. (1997) Focus on the effects of bednets on malaria morbidity and mortality. Parasitol. Today 13, 123-124
4. Greenwood, B.M. (1997) What's new in malaria control? Ann. Trop. Med. Parasitol. 91, 523-531
5. Snow, R.W. and Marsh, K. (1998) New insights into the epidemiology of malaria relevant for disease control. Br. Med. Bull. 54, 293-309
6. Verdrager, J. (1986) Epidemiology of the emergence and spread of drug-resistant falciparum malaria in south-east Asia and Australasia. J. Trop. Med. Hyg. 89, 277-289
7. Shapira, A., Beales, P.F. and Halloran, M.P. (1993) Malaria: Living with drug resistance. Parasitol. Today 9, 168-174
8. Price, R. et al. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347, 1654-1658
9. Molyneux, D.H. and Davies, J.B. (1997) Onchocerciasis control: Moving towards the millennium. Parasitol. Today 13, 418-425
10. Hogh, B. et al. (1998) The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am. J. Trop. Med. Hyg. 58, 176-182
11. World Health Organization (1995) Vector control for malaria and other mosquito-borne diseases. WHO Tech. Rep. Ser. 857
12. Schultz, L.J. et al. (1994) The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am. J. Trop. Med. Hyg. 51, 515-522
13. Brabin, B.J. et al. (1997) Antimalarial drug policy in Malawi. Ann. Trop. Med. Parasitol. 91 (Suppl. 1), S113-S115
14. Mharakurwa, S. et al. (1998) Status of chloroquine efficacy on falciparum malaria in Mola area of Kariba district, Zimbabwe. Ann. Trop. Med. Parasitol. 92, 655-661
15. Phillips, P. and Phillips-Howard, P.A. (1996) Economic implications of resistance to antimalaria drugs. PharmacoEconomics 10, 225-238
16. World Health Organization (1990) Practical chemotherapy of malaria: Report of a WHO Scientific Group. WHO Tech. Rep. Ser. 805
17. Mills, A. (1991) in Malaria: Waiting for the Vaccine (Targett, G.A.T., ed.), pp 141-168, Wiley
18. Mills, A. (1993) Is malaria control a priority? Evidence from Nepal. Health Econ. 2, 333-347
19. Mills, A. (1992) The economic evaluation of malaria control technologies: The case of Nepal. Social Sci. Med. 34, 965-967